Detection of serum IL-6 in patients with diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000188281PMID 7830879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines in sera from insulin‐dependent diabetic patients at diagnosis

  1991cited by this paper
• Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.

  1991cited by this paper
• Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response.

  1989cited by this paper
• Multiple actions of interleukin 6 within a cytokine network.

  1988cited by this paper

• IL-6 and diabetic kidney disease

  2024cites this paper
• Role of Phytochemicals against Diabetic Nephropathy: An Insight into Molecular Receptors

  2023cites this paper
• Pentosan polysulfate exerts anti‐inflammatory effect and halts albuminuria progression in diabetic nephropathy: Role of combined losartan

  2022cites this paper
• Role of Certain Pro-Inflammatory Cytokines in Pathogenicity of Cardiomyopathy in Sample of Iraqi Patients

  2022cites this paper
• Meta-Analysis and Bioinformatics Detection of Susceptibility Genes in Diabetic Nephropathy

  2021cites this paper
• Cadherin and Wnt signaling pathways as key regulators in diabetic nephropathy

  2021cites this paper
• The role of inflammation in diabetic kidney disease

  2021cites this paper
• Acute Kidney Injury in Pediatric Diabetic Kidney Disease

  2021cites this paper
• Exploration of Matrix Metalloproteinase and its Interplay in the Development of Diabetic Nephropathy

  2021cites this paper
• A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity

  2021cites this paper
• Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway

  2020cites this paper
• Insights into predicting diabetic nephropathy using urinary biomarkers.

  2020cites this paper
• Role of the Nox4/AMPK/mTOR signaling axe in adipose inflammation-induced kidney injury.

  2020cites this paper
• Comparative analysis of biochemical parameters and gene expressions of novel markers in type II Diabetes mellitus

  2019cites this paper
• Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose

  2019cites this paper
• Role of cytokines IL-1, IL-6 and TNF-α in the pathogenesis of diabetic nephropathy

  2019cites this paper
• Renal Disease in Diabetes

  2019cites this paper
• Influence of IL-6, IL-10, IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients

  2018cites this paper
• Acute Kidney Injury and Progression of Diabetic Kidney Disease.

  2018cites this paper
• Inflammatory Processes in Diabetic Glomeruli

  2018cites this paper
• Diosgenin glucoside protects against myocardial injury in diabetic mice by inhibiting RIP140 signaling.

  2018cites this paper
• ASSESSMENT OF SERUM IL 6 LEVELS IN PATIENTS WITH DIABETIC NEPHROPATHY AND ITS CORRELATION WITH STAGE OF CHRONIC KIDNEY DISEASE

  2018cites this paper
• 7-Ketocholesterol induces ROS-mediated mRNA expression of 12-lipoxygenase, cyclooxygenase-2 and pro-inflammatory cytokines in human mesangial cells: Potential role in diabetic nephropathy.

  2018cites this paper
• Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

  2017cites this paper
• Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.

  2017cites this paper
• Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.

  2017cites this paper
• Biological factors involved in the modulation of bacterial endotoxin-mediated inflammation in type 1 diabetes

  2017cites this paper
• Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy

  2017cites this paper
• Association between Oxidative Stress, Systemic Inflammation and Renal Function in Type 2 Diabetic Nephropathy

  2017cites this paper
• DRUGS FOR DIABETIC NEPHROPATHY- FULL REVIEW

  2017cites this paper
• The involvement of proinflammatory cytokines in diabetic nephropathy: Focus on interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) signaling mechanism

  2017cites this paper
• Status of pro-inflammatory Marker IL-6 and Microalbuminuria in type- 2 Diabetic Nephropathy subjects

  2017cites this paper
• Antioxidant Status and Anti-inflammatory Effects of Oleuropein in Streptozotocin-induced Diabetic Nephropathy in Rats

  2017cites this paper
• Calcium dobesilate may alleviate diabetes-induced endothelial dysfunction and inflammation

  2017cites this paper
• Study of IL4‐590C/T and IL6‐174G/C Gene Polymorphisms in Type 2 Diabetic Patients With Chronic Kidney Disease in North Indian Population

  2017cites this paper
• A Review on Role of Cytokine Gene Polymorphisms in Type 2 Diabetes Mellitus

  2016cites this paper
• Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway

  2016cites this paper
• Interleukin-6 gene polymorphisms correlate with the progression of nephropathy in Chinese patients with type 2 diabetes: A prospective cohort study.

  2016cites this paper
• Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway

  2016cites this paper
• Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

  2015cites this paper
• Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells.

  2015cites this paper
• Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy

  2015cites this paper
• Association of Interleukin-6 −174 G>C Promoter Polymorphism with Increased Risk of Type 2 Diabetes Mellitus Patients with Diabetic Nephropathy in Turkey

  2014cites this paper
• Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells.

  2014cites this paper
• Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy.

  2014cites this paper
• Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney.

  2014cites this paper
• Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells

  2014cites this paper
• Protective effect of total flavonoids extracted from the leaves of Murraya paniculata (L.) Jack on diabetic nephropathy in rats.

  2014cites this paper
• Inflammation in diabetic kidney disease.

  2014cites this paper
• Inflammation and the pathogenesis of diabetic nephropathy.

  2013cites this paper
• AVALIAÇÃO DA ANEXINA A1, IL-6 E DE VIAS SINALIZADORAS INTRACELULARES NA OBESIDADE E NO DIABETES MELLITUS TIPO 2

  2013cites this paper
• The association of the 174G>C polymorphism of interleukin 6 gene with diabetic nephropathy in patients with type 2 diabetes mellitus.

  2013cites this paper
• The Role of Inflammatory Cytokines in Diabetic Nephropathy: Potential Use as Predictive Markers for Early Detection and Progression

  2013cites this paper
• Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update.

  2013cites this paper
• Microinflammation in the pathogenesis of diabetic nephropathy

  2013cites this paper
• Diabetic nephropathy: traditional to proteomic markers.

  2013cites this paper
• Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.

  2012cites this paper
• Hyperglycemia induced down-regulation of renal P-glycoprotein expression.

  2012cites this paper
• Cytokines in diabetic nephropathy.

  2012cites this paper
• Biomarkers for evaluating renal function decline in diabetes: where are we now?

  2012cites this paper
• Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.

  2012cites this paper
• Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

  2011cites this paper
• The role of inflammatory cytokines in diabetic nephropathy.

  2008cites this paper
• Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: An Egyptian study.

  2007cites this paper
• Renal Pro-Inflammatory Cytokine Gene Expression in Diabetic Nephropathy: Effect of Angiotensin-Converting Enzyme Inhibition and Pentoxifylline Administration

  2007cites this paper
• Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy

  2006cites this paper
• Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

  2005cites this paper
• No association between oxidative stress and IL-6 in NIDDM patients with nephropathy.

  2003cites this paper
• [Diabetic nephropathy. A matter of inflammation?].

  2003cites this paper
• Modificación de los mediadores inflamatorios en isquemia-reperfusión intestinal en un modelo de diabetes tipo 2

  2002cites this paper
• Interleukin‐6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in Type 2 diabetes

  2002cites this paper
• Urinary levels of monocyte chemoattractant protein‐1 (MCP‐1) and interleukin‐8 (IL‐8), and renal injuries in patients with type 2 diabetic nephropathy

  2002cites this paper
• Paramecium aurelia species complex in the catchment area of the River Raba mountain course (the Carpathians).

  2001cites this paper
• Detection of Urinary MCP-1 in Patients withDiabetic Nephropathy

  1998cites this paper
• Lipoproteine und diabetische Nephropathie

  1998cites this paper
• [Lipoproteins and diabetic nephropathy].

  1998cites this paper
• Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment

  1998cites this paper
• Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells

  1996cites this paper